It has been reported that inhibiting caspase 1 antagonizes NLRP3 inflammasome assembly, prevents foam cell formation and pyroptosis in macrophages, partly by boosting Parkin-mediated mitophagy and efferocytosis, and thereby ameliorates vascular inflammation and atherosclerosis [455]. This evidence concerns the gene NLRP3 and atherosclerosis.